What is Sarcopenia?
Sarcopenia is an age associate muscle degenerative disorder, which results in lower muscle mass and strength, leading to a decline in physical capacity.
There are multiple causes for this disorder, however, decrease muscle metabolic activity including lower CoQ10 content, has been extensively characterized in this condition.
Clinical Trial
The Phase II BPGbio’s (BERG) BPM 31510 sarcopenia trial will recruit 40 patients between the ages of 65-90 for this study. Patients will be treated for 28 days and subsequently analyzed for physical and metabolic fitness.
Please check back for more information about BPGbio’s (BERG) BPM 31510 Sarcopenia trial.